Extracorporeal Blood Purification with CytoSorb in 359 Critically Ill Patients
Blood Purification · 2023
DOI: 10.1159/000530872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, 2023. Verfasst von Marina Pieri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Shock, Cardiogenic, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Introduction
Critically ill patients with inflammatory dysregulation and organ disfunction may benefit from blood purification, although the use of this technique has not been described in large case series. We evaluated clinical outcomes and survival in high-risk intensive care unit (ICU) patients who underwent extracorporeal blood purification.
Methods
359 consecutive ICU patients treated with CytoSorb were included.
Results
Main admission diagnoses were 120 (34%) refractory cardiac arrest under mechanical chest compression; 101 (28%) profound cardiogenic shock; 81 (23%) post-cardiotomy cardiogenic shock; and 37 (10%) respiratory failure. Fifteen patients (4%) were positive for SARS-CoV-2 infection. We observed 49% 30-day mortality, 57% ICU mortality, and 62% hospital mortality, all lower than the 71% mortality predicted by SAPS II and 68% predicted by SOFA score. Parameters of shock and organ failure, above all vasoactive inotropic score, reduced during CytoSorb treatment. Multivariable analysis identified SAPS II, lactate dehydrogenase, ICU stay duration, vasoactive inotropic score, lactates, intra-aortic counterpulsation on top of VA-ECMO, and total bilirubin as predictors of mortality. No CytoSorb-related complications occurred.
Conclusion
CytoSorb treatment was effective in reducing laboratory parameters of shock and vasoactive inotropic score with possible survival implications in a large population of critically ill patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Zitieren
APA
Pieri, M., Bonizzoni, M. A., Belletti, A., Calabrò, M. G., Fominskiy, E., Nardelli, P., Ortalda, A., & Scandroglio, A. M. (2023). Extracorporeal Blood Purification with CytoSorb in 359 Critically Ill Patients. Blood Purification. https://doi.org/10.1159/000530872
Vancouver
Pieri M, Bonizzoni MA, Belletti A, Calabrò MG, Fominskiy E, Nardelli P, et al. Extracorporeal Blood Purification with CytoSorb in 359 Critically Ill Patients. Blood Purification. 2023. doi:10.1159/000530872
BibTeX
@article{Pieri2023,
author = {Pieri, Marina and Bonizzoni, Matteo A and Belletti, Alessandro and Calabrò, Maria G and Fominskiy, Evgeny and Nardelli, Pasquale and Ortalda, Alessandro and Scandroglio, Anna M},
title = {Extracorporeal Blood Purification with CytoSorb in 359 Critically Ill Patients},
journal = {Blood Purification},
year = {2023},
doi = {10.1159/000530872}
}
EUVIMED